tiprankstipranks
Advertisement
Advertisement

Healthcare Triangle Executes Reverse Split to Maintain Nasdaq Listing

Story Highlights
  • On February 10, 2026, Healthcare Triangle enacted a 1-for-60 reverse stock split, cutting outstanding shares to about 757,000 while maintaining authorized share levels and preserving shareholder ownership proportions.
  • The reverse split forms a central part of Healthcare Triangle’s strategy to restore compliance with Nasdaq’s $1.00 minimum bid requirement, aiming to stabilize its capital structure and maintain its Nasdaq Capital Market listing under HCTI.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Healthcare Triangle Executes Reverse Split to Maintain Nasdaq Listing

Claim 30% Off TipRanks

Healthcare Triangle ( (HCTI) ) just unveiled an announcement.

On February 10, 2026, Healthcare Triangle, Inc. implemented a 1-for-60 reverse stock split of its common stock, consolidating every 60 shares into one share while keeping the par value and authorized share count unchanged. The move, approved by shareholders at a February 2, 2026 special meeting, reduced outstanding shares from about 45.4 million to roughly 757,000, with no fractional shares issued as holdings were rounded up to the nearest whole share.

The reverse split is a key element of Healthcare Triangle’s plan to regain compliance with Nasdaq’s $1.00 minimum bid price requirement and preserve its Nasdaq Capital Market listing under the ticker HCTI. Existing shareholder ownership percentages remain effectively unchanged aside from rounding, and proportional adjustments were made to options, warrants and other convertible securities, signaling a capital structure reset aimed at stabilizing trading and maintaining market visibility.

The most recent analyst rating on (HCTI) stock is a Hold with a $0.24 price target. To see the full list of analyst forecasts on Healthcare Triangle stock, see the HCTI Stock Forecast page.

Spark’s Take on HCTI Stock

According to Spark, TipRanks’ AI Analyst, HCTI is a Neutral.

The score is weighed down primarily by weak financial performance—deep ongoing losses, margin compression, and heavy negative free cash flow—alongside a strongly bearish price trend below all major moving averages. Corporate actions provide strategic upside via the AI acquisition, but recent convertible/ATM financing introduces dilution risk, and valuation signals are not supportive due to negative earnings.

To see Spark’s full report on HCTI stock, click here.

More about Healthcare Triangle

Healthcare Triangle, Inc., based in Pleasanton, Calif., operates in the healthcare and life sciences technology sector, providing digital transformation solutions such as managed services, cloud enablement and data analytics. Its offerings, including the HITRUST-certified CloudEz and DataEz platforms, target hospitals, health systems, payers and pharma/life sciences firms seeking secure cloud, data lifecycle and interoperability capabilities.

The company focuses on helping highly regulated healthcare and life sciences clients adopt new technologies, improve clinical and business performance and maintain security and compliance. Its expertise spans healthcare IT, data management and cloud-based performance optimization, positioning Healthcare Triangle as a specialist vendor for organizations aiming to enhance health outcomes through technology.

Average Trading Volume: 155,194

Technical Sentiment Signal: Sell

Current Market Cap: $1.42M

Learn more about HCTI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1